Related Experiment Videos
Consider lipoprotein(a), not just apolipoprotein B, when determining low-density lipoprotein for lipoprotein profiles
Clinical Chemistry
|October 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lipoprotein(a) at birth, in blacks and whites.
Atherosclerosis·1992
Human lipoprotein(a) quantified by 'capture' ELISA.
Annals of clinical and laboratory science·1991
[Left coronary artery originating from the pulmonary artery as a syndrome found in infancy, childhood and adulthood].
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde·1983
Optimal Positive Control Assays for Methylation-Specific PCR.
Clinical chemistry·2026
Clinical Utility and Diagnostic Performance of (1→3)-β-D-Glucan in Invasive Mycoses.
Clinical chemistry·2026
Genetic Investigation of X-Linked Defects with Optimized Targeted Long-Read Sequencing.
Clinical chemistry·2026
Extending Quality Control Procedures for Multiplexed Clinical Assays.
Clinical chemistry·2026
Orbital Septal Fascial Flap with Extensive Release of a Long Orbital Fat Flap for Correcting Lower Eyelid Bags Associated with Midface Depression.
Journal of visualized experiments : JoVE·2026
Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis.
Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity.
Journal of extracellular biology·2026
Prevalence and Associated Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease Across Obesity Metabolic Phenotypes in Chronic Schizophrenia.
International journal of general medicine·2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysis.
Therapeutic advances in neurological disorders·2026